Results 101 to 110 of about 28,278 (262)

Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis. [PDF]

, 2020
There are limited treatment options for immunosuppressed patients with lethal invasive fungal infections due to Fusarium and Scedosporium Manogepix (MGX; APX001A) is a novel antifungal that targets the conserved Gwt1 enzyme required for localization of ...
Alkhazraji, Sondus, Alqarihi, Abdullah, Gebremariam, Teclegiorgis, Gu, Yiyou, Ibrahim, Ashraf S, Mamouei, Zeinab, Shaw, Karen J, Singh, Shakti, Wiederhold, Nathan P   +8 more
core   +1 more source

Invasive pulmonary aspergillosis in patients with acute respiratory syndrome by COVID-19

, 2022
Cyntia Sánchez Martín, E. Martínez, Rosa Pellicer, R. Armero Ibáñez, E. Martínez González, Juan V. Llau   +5 more
openalex   +2 more sources

Galactomannan Does Not Precede Major Signs on a Pulmonary Computerized Tomographic Scan Suggestive of Invasive Aspergillosis in Patients with Hematological Malignancies [PDF]

, 2017
Background. Detection of serum galactomannan (GM) antigen and presence of the halo sign on a pulmonary computerized tomographic (CT) scan have a high specificity but a low sensitivity to diagnose invasive aspergillosis (IA) in patients at risk for this ...
Buitrago, C., Droll, A., Fluckiger, U., Gratwohl, A., Passweg, J., Rausch, C., Sendi, P., Simcock, M., Sonnet, S., Steffen, I., Weisser, M.   +10 more
core  

[Invasive pulmonary aspergillosis in influenza]. [PDF]

Nederlands tijdschrift voor geneeskunde, 2015
BACKGROUND: Invasive pulmonary aspergillosis (IPA) is a life-threatening infection that occurs predominantly in severely immunocompromised patients. Recently, IPA is also increasingly seen in less severely immunocompromised patients, such as patients with COPD receiving glucocorticoids and patients on ventilation in an IC unit.
Kolwijck, E., Scheper, H., Beuving, J., Kuijper, E.J., Hoeven, J.G. van der, Verweij, P.E.   +5 more
openaire   +2 more sources

Treatment and timing in invasive mould disease [PDF]

, 2017
Invasive mould disease is a growing threat for immunocompromised patients. The optimum time to use mould-active antifungal agents is much debated. Current approaches to antifungal prophylaxis, early treatment (empirical and pre-emptive therapy) and ...
Cordonnier, Catherine, de la Cámara, Rafael, Groll, Andreas H., Maertens, Johan, Marchetti, Oscar, Roilides, Emmanuel   +5 more
core  

Subacute invasive pulmonary aspergillosis in a nondiabetic immunocompetent female suffering from allergic broncho pulmonary aspergillosis

, 2023
Subodh Kumar, Devesh Pratap Singh, Sana Ansari, Vivek Hada   +3 more
openalex   +1 more source

Improving survival of acute-on-chronic liver failure patients complicated with invasive pulmonary aspergillosis [PDF]

, 2018
Jie Gao, Qing Zhang, Yuankui Wu, Ying Li, Tingting Qi, Congyan Zhu, Sijia Liu, Ruoxi Yu, Qinjun He, Weiqun Wen, Fuyuan Zhou, Yongpeng Chen, Jinjun Chen, Jinlin Hou   +13 more
openalex   +1 more source

Crazy Paving Pattern Due to Invasive Pulmonary Aspergillosis: A Rare Case Report with Literature Review

, 2023
K. Deependra, Prashant Kumar
openalex   +1 more source

Variability of voriconazole plasma levels measured by new high-performance liquid chromatography and bioassay methods, [and] Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes [PDF]

, 2010
Rapport de synthèse1. Partie de laboratoireCette première étude décrit le développement et la validation, selon les standards internationaux, de deux techniques de mesure des concentrations sanguines de voriconazole, un nouvel agent antifongique à large ...
Pascual, A.
core  

Recent Developments in Inhaled Triazoles Against Invasive Pulmonary Aspergillosis [PDF]

, 2014
Romain Merlos, Karim Amighi, Nathalie Wauthoz   +2 more
openalex   +1 more source